Bavarian Nordic A/S (BVNRY)
OTCMKTS · Delayed Price · Currency is USD
12.44
+0.13 (1.07%)
Aug 22, 2025, 2:36 PM EDT
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of $2.89 billion as of August 22, 2025. Its market cap has increased by 41.25% in one year.
Market Cap
2.89B
Enterprise Value
2.72B
Revenue
1.02B
Ranking
n/a
PE Ratio
12.91
Stock Price
$12.44
Market Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 6.78M to 2.89B, an increase of 42,519.79%. That is a compound annual growth rate of 25.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 2.89B | 39.64% |
| Dec 30, 2024 | 2.07B | 0.95% |
| Dec 29, 2023 | 2.05B | -5.24% |
| Dec 30, 2022 | 2.16B | -24.82% |
| Dec 30, 2021 | 2.88B | 59.81% |
| Dec 30, 2020 | 1.80B | 116.49% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 633.65M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 594.33M |
| American Oncology Network | 385.33M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 368.43M |